In this study, the authors focus on specifically which types of networks and what types of rela-tionships matter most for the focal firm’s innovative performance in biotechnology patenting. They suggest that certain network characteristics, such as quality and the source of knowledge, and the quality of relationships among actors may have a profound effect on the knowledge exchange and hence the number of patents granted to the firm. The authors focus on the research coauthorship networks of 381 firms in the U.S. biotechnology industry over a span of 17 years, from 1990 to 2006. In the biotechnology industry, firms depend heavily on the social network of academic scientists for the exchange and production of knowledge, with firm-level paten...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
In this study, the authors focus on specifically which types of networks and what types of rela-tion...
Thesis (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and P...
This is the first book that comprehensively analyses co-patenting in Japan and the U.S., which direc...
In settings where patents and intellectual property provide a strong regime of appropriability, the ...
Knowledge intensive or high-tech industries are widely regarded as important for overall national ec...
This paper aims at explaining whether R&D subsidies, the engagement in collaboration networks and t...
[[abstract]]Patents are important intellectual assets. Approaches to evaluating patent quality are m...
This paper aims at explaining whether R&D subsidies, the engagement in collaboration networks and t...
Innovation is critical for harmonizing goals economic prosperity and environmental sustainability, b...
Departing from prior research analyzing the implications of social structure for actors' outcomes by...
Knowledge intensive or high-tech industries are widely regarded as important for overall national ec...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
In this study, the authors focus on specifically which types of networks and what types of rela-tion...
Thesis (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and P...
This is the first book that comprehensively analyses co-patenting in Japan and the U.S., which direc...
In settings where patents and intellectual property provide a strong regime of appropriability, the ...
Knowledge intensive or high-tech industries are widely regarded as important for overall national ec...
This paper aims at explaining whether R&D subsidies, the engagement in collaboration networks and t...
[[abstract]]Patents are important intellectual assets. Approaches to evaluating patent quality are m...
This paper aims at explaining whether R&D subsidies, the engagement in collaboration networks and t...
Innovation is critical for harmonizing goals economic prosperity and environmental sustainability, b...
Departing from prior research analyzing the implications of social structure for actors' outcomes by...
Knowledge intensive or high-tech industries are widely regarded as important for overall national ec...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...
With increasing dynamics and complexity in the biotechnology industry, pharmaceutical companies are...